Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer

Prostate cancer is a common malignancy in men around the world, and it is crucial to explore novel biomarkers to improve its treatment. Prostate cancer cells typically invade the surrounding stroma, and remodeling of the extracellular matrix (ECM) is a crucial step in the progress of prostate cancer...

Full description

Saved in:
Bibliographic Details
Main Authors: Ai Sato, Kiyoshi Takagi, Mio Yamaguchi-Tanaka, Jotaro Okushima, Yuto Yamazaki, Akihiro Ito, Takashi Suzuki
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Experimental and Molecular Pathology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0014480025000036
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823859455409782784
author Ai Sato
Kiyoshi Takagi
Mio Yamaguchi-Tanaka
Jotaro Okushima
Yuto Yamazaki
Akihiro Ito
Takashi Suzuki
author_facet Ai Sato
Kiyoshi Takagi
Mio Yamaguchi-Tanaka
Jotaro Okushima
Yuto Yamazaki
Akihiro Ito
Takashi Suzuki
author_sort Ai Sato
collection DOAJ
description Prostate cancer is a common malignancy in men around the world, and it is crucial to explore novel biomarkers to improve its treatment. Prostate cancer cells typically invade the surrounding stroma, and remodeling of the extracellular matrix (ECM) is a crucial step in the progress of prostate cancer. Matrix metalloproteinase-3 (MMP3) is an enzyme that degrades several ECM components and is implicated in human malignancies. However, the clinical and biological significance of MMP3 has not been well elucidated.We therefore immunolocalized MMP3 in prostate cancer tissues (n = 117) and demonstrated that MMP3 immunoreactivity was correlated with aggressive phenotype of prostate cancer, including higher proliferation/invasion ability, and shorter disease-free survival. In addition, subsequent in vitro analysis revealed that overexpression of MMP3 significantly increased the proliferative and migratory abilities of PC-3 and DU-145 prostate cancer cell lines, depending on conditioned media from WMPY-1 prostate stromal cells.It was concluded that MMP3 might contribute to prostate cancer progression by modifying the ECM surrounding prostate cancer cells and could serve as a potent prognostic factor in prostate cancer.
format Article
id doaj-art-2848bfe9b226437eb7268fb0123a6976
institution Kabale University
issn 1096-0945
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Experimental and Molecular Pathology
spelling doaj-art-2848bfe9b226437eb7268fb0123a69762025-02-11T04:33:28ZengElsevierExperimental and Molecular Pathology1096-09452025-03-01141104954Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancerAi Sato0Kiyoshi Takagi1Mio Yamaguchi-Tanaka2Jotaro Okushima3Yuto Yamazaki4Akihiro Ito5Takashi Suzuki6Departments of Pathology and Histotechnology, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, JapanDepartments of Pathology and Histotechnology, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan; Corresponding author.Departments of Pathology and Histotechnology, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan; Departments of Personalized Medicine Center, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, JapanDepartments of Pathology and Histotechnology, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, JapanDepartment of Pathology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, JapanDepartments of Urology, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, JapanDepartments of Pathology and Histotechnology, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan; Department of Pathology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan; Departments of Anatomic Pathology Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, JapanProstate cancer is a common malignancy in men around the world, and it is crucial to explore novel biomarkers to improve its treatment. Prostate cancer cells typically invade the surrounding stroma, and remodeling of the extracellular matrix (ECM) is a crucial step in the progress of prostate cancer. Matrix metalloproteinase-3 (MMP3) is an enzyme that degrades several ECM components and is implicated in human malignancies. However, the clinical and biological significance of MMP3 has not been well elucidated.We therefore immunolocalized MMP3 in prostate cancer tissues (n = 117) and demonstrated that MMP3 immunoreactivity was correlated with aggressive phenotype of prostate cancer, including higher proliferation/invasion ability, and shorter disease-free survival. In addition, subsequent in vitro analysis revealed that overexpression of MMP3 significantly increased the proliferative and migratory abilities of PC-3 and DU-145 prostate cancer cell lines, depending on conditioned media from WMPY-1 prostate stromal cells.It was concluded that MMP3 might contribute to prostate cancer progression by modifying the ECM surrounding prostate cancer cells and could serve as a potent prognostic factor in prostate cancer.http://www.sciencedirect.com/science/article/pii/S0014480025000036Matrix metalloproteinase-3Prostate cancerExtracellular matrixPrognosisImmunohistochemistry
spellingShingle Ai Sato
Kiyoshi Takagi
Mio Yamaguchi-Tanaka
Jotaro Okushima
Yuto Yamazaki
Akihiro Ito
Takashi Suzuki
Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer
Experimental and Molecular Pathology
Matrix metalloproteinase-3
Prostate cancer
Extracellular matrix
Prognosis
Immunohistochemistry
title Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer
title_full Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer
title_fullStr Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer
title_full_unstemmed Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer
title_short Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer
title_sort matrix metalloproteinase 3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer
topic Matrix metalloproteinase-3
Prostate cancer
Extracellular matrix
Prognosis
Immunohistochemistry
url http://www.sciencedirect.com/science/article/pii/S0014480025000036
work_keys_str_mv AT aisato matrixmetalloproteinase3isapotentprognosticfactorassociatedwithcellproliferationandmigrationinprostatecancer
AT kiyoshitakagi matrixmetalloproteinase3isapotentprognosticfactorassociatedwithcellproliferationandmigrationinprostatecancer
AT mioyamaguchitanaka matrixmetalloproteinase3isapotentprognosticfactorassociatedwithcellproliferationandmigrationinprostatecancer
AT jotarookushima matrixmetalloproteinase3isapotentprognosticfactorassociatedwithcellproliferationandmigrationinprostatecancer
AT yutoyamazaki matrixmetalloproteinase3isapotentprognosticfactorassociatedwithcellproliferationandmigrationinprostatecancer
AT akihiroito matrixmetalloproteinase3isapotentprognosticfactorassociatedwithcellproliferationandmigrationinprostatecancer
AT takashisuzuki matrixmetalloproteinase3isapotentprognosticfactorassociatedwithcellproliferationandmigrationinprostatecancer